• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza virus activity in the world - 30 March 2012 (WHO, edited)

Giuseppe

Emeritus
[Source: World Health Organization, full page: (LINK). Edited.]

Influenza virus activity in the world - 30 March 2012


Source: Laboratory confirmed data from the Global Influenza Surveillance and Response System (GISRS).



Based on FluNet reporting (as of 27 March 2012, 14:00 UTC) during weeks 10 to 11 (4 March 2012 to 17 March 2012), National Influenza Centres (NICs) and other national influenza laboratories from 88 countries, areas or territories reported data.

The WHO GISRS laboratories tested more than 50,919 specimens. 15,214 were positive for influenza viruses, of which 11,559 (76%) were typed as influenza A and 3,655 (24%) as influenza B.

Of the sub-typed influenza A viruses, 957 (15%) were influenza A(H1N1)pdm09 and 5,351 (85%) were influenza A(H3N2).

Of the characterized B viruses, 420 (45%) belong to the B-Yamagata lineage and 509 (55%) to the B-Victoria lineage.



Summary

During weeks 10 and 11 in 2012, laboratory confirmed influenza activity continued to increase in many countries in the northern hemisphere with regional and widespread outbreaks reported in a number of countries.

Influenza A(H3N2) continued to be the predominant virus subtype detected globally.

In general, influenza A(H1N1)pdm09 remained low with the exception of a few countries.

Influenza B virus activity was high in a number of countries and was the predominant virus detected in Canada and China.

In Europe, outbreaks of influenza A(H3N2) were reported with increasing co-circulation of influenza B in some countries.

In northern Africa, influenza A(H3N2) activity decreased with local outbreaks reported only in Algeria.

In the United States of America, influenza A(H3N2) remained the predominant virus subtype while in Canada influenza B detections continued to increase and surpassed the number of influenza A viruses reported.

A(H1N1)pdm09 viruses remained the predominant virus subtype in Mexico. A(H1N1)pdm09 viruses were reported in increasing proportions in some regions in the United States of America.

In Central America, influenza activity increased in Guatemala with A(H1N1)pdm09 viruses the main circulating virus subtype.

In Asia, A(H3N2) and B virus influenza activity remained high, with B viruses predominating in China, China Hong Kong Special Administrative Region and the Republic of Korea.

Influenza A(H3N2) viruses remained predominant in Japan with some co-circulation of influenza B. In the Middle East, A(H1N1)pdm09 activity increased in Qatar.

In the southern hemisphere, influenza activity continued to be low with the majority of the sporadic virus detections identified as influenza A(H3N2).
-
------
 
Back
Top Bottom